• 13 DE
• 14 EN

• 9 Home
• 10 Contact
• 11 Sitemap

• 7 Press
  • 7.1 Press Releases
    • 7.1.1 Company
      • 7.1.1.1 2000
      • 7.1.1.2 2009
      • 7.1.1.3 2010
      • 7.1.1.4 2001
      • 7.1.1.5 2002
      • 7.1.1.6 2003
      • 7.1.1.7 2004
      • 7.1.1.8 2005
      • 7.1.1.9 2006
      • 7.1.1.10 2007
      • 7.1.1.11 2008
    • 7.1.2 Health
  • 7.2 Photos & Logos

Changes in the Merz Group Management

Dr. Martin Zügel appointed Chairman of the Management Board / Dr. Matthias Vogt assumes the position of Chief Financial Officer

Frankfurt am Main, 02.07.2008

Dr. Martin Zügel, member of the Merz Management Board responsible as CEO of Merz Pharmaceuticals for research, development and sales of pharmaceutical products, is to head the Management Board as its Chairman. Dr. Matthias Vogt, who will be joining the Merz Group as Chief Financial Officer on 2 July 2008, is a new member of the Management Board.

Dr. Martin Zügel, CEO of the company with the highest sales of the Merz Group, Merz Pharmaceuticals GmbH, was appointed Chairman of the Management Board. He joined Merz in April 2005 as a member of the Management Board and Head of Merz Pharmaceuticals GmbH. "Dr. Martin Zügel has served Merz exceptionally well. Research and development activities were expanded under his leadership, the internationalization of the pharmaceutical line of business forged ahead with the Group's own subsidiaries towards positioning the company well to master the challenges of the future," says Dr. Jochen Hückmann, Chairman of the Shareholders´Council.

On 2 July 2008 Dr. Matthias Vogt will be taking up the position of CFO within the Merz Group. Dr. Vogt has degrees in Business Management and Industrial Engineering. In his professional career he filled various international management posts for Novartis and was most recently CFO for their global OTC line of business.
"We are delighted that with Dr. Matthias Vogt, we have gained someone who is highly qualified to promote the international business conducted by our company," Dr. Jochen Hückmann explains.

Armin von Buttlar, who joined the Merz Group as CFO on 1 March 2006, has decided to leave the company to concentrate on new tasks. He will be leaving the Merz Group on 30 June. Armin von Buttlar notably made a great contribution towards establishing a modern, revealing financial and controlling system which was launched at group level in accordance with international standards. He was instrumental in successfully supervising major acquisition and financial transactions and made significant contributions towards long-term planning in the company. "We regret that Mr von Buttlar is leaving the company and wish him all the best for the future," said Dr. Jochen Hückmann.

About Merz

Medicinal products for treating neurological any psychological illnesses are the main line of Merz business. The company is a leader in the area of Alzheimer research. With Memantine, Merz developed the first substance in the world for treating moderate to severe stages of Alzheimer. Memantine is the second most popular Alzheimer medication worldwide. Another area of Merz expertise is clinical and aesthetic dermatology. In addition to the pharmaceutical market, Merz also operates in the health sector beyond the scope of pharmacies. With its established tetesept® and Merz Spezial® brands, Merz Consumer Care is one of the leading suppliers of self-medication, dietary supplement and skin care products in the German-speaking world. Senator GmbH & Co. KGaA, a Merz subsidiary, is one of the leading manufacturers of writing utensils on the world market for promotional items. The Merz Group has a staff of 2,050 employees worldwide (previous year 1,915 employees). In 2006 / 2007 the company generated sales amounting to around 535 million euros (previous year around 474 million euros).

Download

Press Release

Your contact person

Merz GmbH & Co. KGaA
Ute Weinhold
Corporate Communications
Eckenheimer Landstraße 100
60318 Frankfurt
Tel + 49 - 69 - 15 03 - 889
Fax + 49 - 69 - 15 03 - 581

E-Mail: ute.weinhold@merz.de

• 0.1 A-
• 0.2 A
• 0.3 A+
• 0.4 Print

Search

Search

Search

Login for Professionals

Login for Professionals

Merz DocCheck User Password

new user

German Websites

• Alzheimer´s
• Depression
• Dystonia
• Hair Loss
• Hyal-System
• Liver Disease
• Parkinson´s